Condensed Consolidated Statements of Stockholders' Deficit - USD ($) shares in Thousands, $ in Thousands		Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss		Retained Earnings	Treasury Stock	Noncontrolling Interests in Subsidiaries
Beginning balance (in shares) at Dec. 31, 2023			32,488
Beginning balance at Dec. 31, 2023		$ (443,616)	$ 492	$ 452,290	$ (7,803)	[1]	$ 219,027	$ (1,123,098)	$ 15,476
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	[2]	69,005					68,687		318
Other comprehensive income (loss), net of tax		1,223			1,223	[1]
Dividends on common stock		(45,350)		95			(45,445)
Exercise of stock options (in shares)			22
Exercise of stock options		1,021	$ 1	1,020
Stock-based compensation expense		5,903		5,903
Issuance of restricted stock (in shares)			171
Issuance of restricted stock		0		(6,242)				6,242
Tax effect of restricted stock awards (in shares)			(52)
Tax effect of restricted stock awards		(3,508)		(3,508)
Distributions to noncontrolling interests		(480)							(480)
Other (in shares)			8
Other		183		(417)				600
Ending balance (in shares) at Sep. 29, 2024			32,637
Ending balance at Sep. 29, 2024		(415,619)	$ 493	449,141	(6,580)	[1]	242,269	(1,116,256)	15,314
Beginning balance (in shares) at Jun. 30, 2024			32,622
Beginning balance at Jun. 30, 2024		(446,140)	$ 493	446,547	(7,358)	[1]	215,800	(1,117,140)	15,518
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	[2]	41,745					41,808		(63)
Other comprehensive income (loss), net of tax		778			778	[1]
Dividends on common stock		(15,308)		31			(15,339)
Exercise of stock options (in shares)			2
Exercise of stock options		88		88
Stock-based compensation expense		3,358		3,358
Issuance of restricted stock (in shares)			14
Issuance of restricted stock		0		(632)				632
Tax effect of restricted stock awards (in shares)			(4)
Tax effect of restricted stock awards		(178)		(178)
Distributions to noncontrolling interests		(141)							(141)
Other (in shares)			3
Other		179		(73)				252
Ending balance (in shares) at Sep. 29, 2024			32,637
Ending balance at Sep. 29, 2024		$ (415,619)	$ 493	449,141	(6,580)	[1]	242,269	(1,116,256)	15,314
Beginning balance (in shares) at Dec. 29, 2024		32,600	32,646
Beginning balance at Dec. 29, 2024		$ (414,216)	$ 493	452,449	(8,456)	[3]	241,717	(1,115,729)	15,310
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	[4]	23,403					23,460		(57)
Other comprehensive income (loss), net of tax		1,723			1,723	[3]
Dividends on common stock		(46,060)		76			(46,136)
Exercise of stock options (in shares)			9
Exercise of stock options		397		397
Stock-based compensation expense		12,132		12,132
Issuance of restricted stock (in shares)			153
Issuance of restricted stock		(16)		(7,376)				7,360
Tax effect of restricted stock awards (in shares)			(40)
Tax effect of restricted stock awards		(1,791)		(1,791)
Distributions to noncontrolling interests		(324)							(324)
Other (in shares)			18
Other		$ 376		(788)				1,164
Ending balance (in shares) at Sep. 28, 2025		32,800	32,786
Ending balance at Sep. 28, 2025		$ (424,376)	$ 493	455,099	(6,733)	[3]	219,041	(1,107,205)	14,929
Beginning balance (in shares) at Jun. 29, 2025			32,753
Beginning balance at Jun. 29, 2025		(416,754)	$ 493	452,787	(5,967)	[3]	229,868	(1,109,178)	15,243
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	[4]	4,441					4,707		(266)
Other comprehensive income (loss), net of tax		(766)			(766)	[3]
Dividends on common stock		(15,511)		23			(15,534)
Exercise of stock options		0
Stock-based compensation expense		4,639		4,639
Issuance of restricted stock (in shares)			43
Issuance of restricted stock		(1)		(1,770)				1,769
Tax effect of restricted stock awards (in shares)			(13)
Tax effect of restricted stock awards		(583)		(583)
Distributions to noncontrolling interests		(48)							(48)
Other (in shares)			3
Other		$ 207		3				204
Ending balance (in shares) at Sep. 28, 2025		32,800	32,786
Ending balance at Sep. 28, 2025		$ (424,376)	$ 493	$ 455,099	$ (6,733)	[3]	$ 219,041	$ (1,107,205)	$ 14,929

[1] At September 29, 2024, the accumulated other comprehensive loss of $6,580 was comprised of net unrealized foreign currency translation loss of $6,186 and net unrealized gain on the interest rate swap agreements of $394.

[2] Net income to the Company for the three and nine months ended September 29, 2024 excludes $43 and $233, respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.

[3] At September 28, 2025, the accumulated other comprehensive loss of $6,733 was comprised of net unrealized foreign currency translation loss of $6,187 and net unrealized loss on the interest rate swap agreements of $546.

[4] Net income to the Company for the three and nine months ended September 28, 2025 excludes $32 and $84, respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.